Mortality in patients with chronic obstructive pulmonary disorder undergoing transcatheter aortic valve replacement: The importance of chronic obstructive pulmonary disease exacerbation.
Marie Dam LauridsenJan Brink ValentinJarl Emanuel StrangePeter A JacobsenLars KøberUlla WeinreichSøren Paaske JohnsenEmil FosbølPublished in: American heart journal (2023)
Among patients undergoing TAVR, increasing risk of exacerbation with COPD was associated with increasing 1-year mortality compared with non-COPD patients. Patients with a high risk of exacerbation with COPD not using any guideline recommended COPD medication and those using home oxygen had the highest 1-year mortality.
Keyphrases
- chronic obstructive pulmonary disease
- transcatheter aortic valve replacement
- lung function
- aortic stenosis
- aortic valve
- cardiovascular events
- patients undergoing
- ejection fraction
- end stage renal disease
- risk factors
- newly diagnosed
- healthcare
- peritoneal dialysis
- coronary artery disease
- cardiovascular disease
- chronic kidney disease
- emergency department
- patient reported outcomes
- left ventricular
- atrial fibrillation
- air pollution